Perceptive Advisors, a life sciences investment firm, led the financing round to support the Physera acquisition and provide additional support for future growth, according to a news release.
Omada Health offers digital health programs to support patients with Type 2 diabetes, hypertension and behavioral health issues. By acquiring Physera, Omada Health will now offer members video appointments with a network of licensed physical therapists for diagnosis and treatment as well as digital exercise therapy and in-app animations to help reduce musculoskeletal pain.
Both Omada and Physera sell to health plans and employers. Omada Health has raised more than $250 million to date, according to CNBC. Last October, the company raised $73 million from investors including Cigna Ventures, Kaiser Permanente and Providence Ventures.
More articles on digital transformation:
Lee Health to employ digital technology to limit COVID-19 exposure in potential surge
Fitbit to develop emergency ventilators
‘We either have to succeed fast or fail fast’: How Houston Methodist’s innovation hub is making its mark
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
